| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Tony P George | |
| Konstantine K Zakzanis | |||
| Rachel A Rabin | |||
| P433 | issue | 1-3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | schizophrenia | Q41112 |
| meta-analysis | Q815382 | ||
| effects of cannabis | Q4358078 | ||
| P304 | page(s) | 111-116 | |
| P577 | publication date | 2011-03-21 | |
| P1433 | published in | Schizophrenia Research | Q7431607 |
| P1476 | title | The effects of cannabis use on neurocognition in schizophrenia: a meta-analysis | |
| P478 | volume | 128 |
| Q35356756 | AKT1 moderation of cannabis-induced cognitive alterations in psychotic disorder |
| Q30417841 | Acute administration of Δ⁹ tetrahydrocannabinol does not prevent enhancement of sensory gating by clozapine in DBA/2 mice |
| Q38379526 | Adolescent Initiation of Cannabis Use and Early-Onset Psychosis |
| Q55617842 | Age at Onset and Social Cognitive Impairment in Clinically Stabilized Patients with Schizophrenia: An Ecological Cross-Sectional Study. |
| Q36354947 | An fMRI Study of Neuronal Activation in Schizophrenia Patients with and without Previous Cannabis Use. |
| Q52625218 | Are cannabis-using and non-using patients different groups? Towards understanding the neurobiology of cannabis use in psychotic disorders. |
| Q52600030 | Associations between adolescent cannabis use and brain structure in psychosis. |
| Q35243704 | Attention/vigilance in schizophrenia: performance results from a large multi-site study of the Consortium on the Genetics of Schizophrenia (COGS). |
| Q34530176 | BRIEF REPORT: THE IMPACT OF ALCOHOL AND CANNABIS MISUSE ON COGNITION AMONG INDIVIDUALS WITH SCHIZOPHRENIA. |
| Q38950359 | Cannabis and development of dual diagnoses: A literature review |
| Q59208845 | Cannabis and mental illness in adolescents: a review |
| Q88907845 | Cannabis regulatory science: risk-benefit considerations for mental disorders |
| Q50434552 | Cannabis use and cognitive function in first episode psychosis: differential effect of heavy use. |
| Q44906174 | Cannabis use and cognitive functions in at-risk mental state and first episode psychosis |
| Q35534902 | Cognitive and clinical outcomes associated with cannabis use in patients with bipolar I disorder. |
| Q39452682 | Cognitive development prior to onset of psychosis |
| Q47945952 | Cognitive functioning associated with stimulant use in patients with non-affective psychosis, their unaffected siblings and healthy controls |
| Q38124448 | Comorbid substance use disorder in schizophrenia: a selective overview of neurobiological and cognitive underpinnings |
| Q58599983 | Connectivity Analyses of Bioenergetic Changes in Schizophrenia: Identification of Novel Treatments |
| Q42601467 | Dronabinol, a cannabinoid agonist, reduces hair pulling in trichotillomania: a pilot study |
| Q92238326 | Early Substance Use Cessation Improves Cognition-10 Years Outcome in First-Episode Psychosis Patients |
| Q47739996 | Effects of Extended Cannabis Abstinence on Cognitive Outcomes in Cannabis Dependent Patients with Schizophrenia vs Non-Psychiatric Controls |
| Q37285509 | Evaluating the relationship between cannabis use and IQ in youth and young adults at clinical high risk of psychosis |
| Q39517216 | Executive functioning in individuals with schizophrenia and/or cocaine dependence. |
| Q26865311 | Gone to Pot - A Review of the Association between Cannabis and Psychosis |
| Q47439536 | Heavy cannabis use prior psychosis in schizophrenia: clinical, cognitive and neurological evidences for a new endophenotype? |
| Q35216772 | Hemispheric language asymmetry in first episode psychosis and schizotypy: the role of cannabis consumption and cognitive disorganization |
| Q36577094 | Inferior performance on selected neuropsychological tests in abstinent schizophrenia patients who have used cannabis. |
| Q37358080 | MAPK14 and CNR1 gene variant interactions: effects on brain volume deficits in schizophrenia patients with marijuana misuse |
| Q33762494 | Neurocognitive functioning of individuals with schizophrenia: using and not using drugs |
| Q35624088 | Neuropsychological deficits associated with cannabis use in young adults |
| Q36101350 | Opposite Cannabis-Cognition Associations in Psychotic Patients Depending on Family History |
| Q34378233 | Pathways from cannabis to psychosis: a review of the evidence |
| Q38996589 | Pros and Cons of Medical Cannabis use by People with Chronic Brain Disorders |
| Q50624456 | Relationship between tobacco and cannabis use status in outpatients with schizophrenia. |
| Q35019595 | Risk-taking in schizophrenia and controls with and without cannabis dependence |
| Q35301038 | Social functioning trajectories of young first-episode psychosis patients with and without cannabis misuse: a 30-month follow-up study. |
| Q34531537 | The Cannabis Pathway to Non-Affective Psychosis may Reflect Less Neurobiological Vulnerability |
| Q36386484 | The Role of Endocannabinoid Signaling in Cortical Inhibitory Neuron Dysfunction in Schizophrenia |
| Q58779432 | The adverse health effects and harms related to marijuana use: an overview review |
| Q50562471 | The effects of cannabis on memory function in users with and without a psychotic disorder: findings from a combined meta-analysis. |
| Q45737010 | The impact of alcohol and illicit drugs on people with psychosis: the second Australian National Survey of Psychosis |
| Q37061404 | The neural correlates of mental rotation abilities in cannabis-abusing patients with schizophrenia: an FMRI study |
| Q45767391 | Under-reporting of drug use among individuals with schizophrenia: prevalence and predictors |
| Q38639956 | Understanding marijuana's effects on functional connectivity of the default mode network in patients with schizophrenia and co-occurring cannabis use disorder: A pilot investigation. |
| Q26742198 | Unraveling Executive Functioning in Dual Diagnosis |
Search more.